Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Charles, Ferro"'
Autor:
Nathan R. Hill, Daniel Lasserson, Ben Thompson, Rafael Perera-Salazar, Jane Wolstenholme, Peter Bower, Thomas Blakeman, David Fitzmaurice, Paul Little, Gene Feder, Nadeem Qureshi, Maarten Taal, Jonathan Townend, Charles Ferro, Richard McManus, F. D. Richard Hobbs
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/881d5faeee0b45829ab789f7171b3220
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Patients with chronic kidney disease have worse outcomes after stroke. However, the burden of acute kidney injury after stroke has not been extensively investigated. Methods We used MEDLINE and Embase to conduct a systematic revie
Externí odkaz:
https://doaj.org/article/88cf05b764834974ac8f0f27b39f9ee6
Autor:
Praveen Sharma, Paul Cockwell, Thomas Dietrich, Charles Ferro, Natalie Ives, Iain L. C. Chapple
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-10 (2017)
Abstract Background Patients with chronic kidney disease (CKD) exhibit increased morbidity and mortality which is associated with an increased systemic inflammatory burden. Identifying and managing comorbid diseases that contribute to this load may i
Externí odkaz:
https://doaj.org/article/79dd56c7cbbb462eb3dc101286b45719
Autor:
Nerissa Jurawan, Tanya Pankhurst, Charles Ferro, Peter Nightingale, Jamie Coleman, David Rosser, Simon Ball
Publikováno v:
BMC Nephrology, Vol 18, Iss 1, Pp 1-11 (2017)
Abstract Background Acute Kidney Injury (AKI) has evoked much interest over the past decade and is reported to be associated with high inpatient mortality. Preventable death and increased readmission rates related to AKI have been the focus of consid
Externí odkaz:
https://doaj.org/article/84cf64078f92436594b7af55f89b2450
Autor:
Alexandra Gallagher, Blaise Agresta, Brendan Smyth, Meg Jardine, Charles Ferro, Rachael L Morton
Publikováno v:
Clinical Kidney Journal. 15:1049-1059
Background Individuals with chronic kidney disease (CKD) are at a very high risk for atherosclerotic cardiovascular disease (ASCVD). New lipid-lowering agents offer hope of improved outcomes where traditional agents have been less efficacious, yet th
Autor:
Jonathan Law, Syeeda Kabir, Christopher O'Shea, Lucy Gallagher, Jenny Morgan, Winnie Chua, Jonathan Townend, Charles Ferro, Davor Pavlovic
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:80-81
Autor:
Richard J Silverwood, Marcus Richards, Mary Pierce, Rebecca Hardy, Naveed Sattar, Charles Ferro, Caroline Savage, Diana Kuh, Dorothea Nitsch, NSHD scientific and data collection teams
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86743 (2014)
Previous studies have found associations between cognitive function and chronic kidney disease. We aimed to explore possible explanations for this association in the Medical Research Council National Survey of Health and Development, a prospective bi
Externí odkaz:
https://doaj.org/article/0978204e952647e680bdd5d35fdef86f
Publikováno v:
The New England journal of medicine. 382(21)
Autor:
Dimitrios, Chanouzas, Lovesh, Dyall, Peter, Nightingale, Charles, Ferro, Paul, Moss, Matthew David, Morgan, Lorraine, Harper
Publikováno v:
Trials
Background The ANCA-associated vasculitides (AAV) are systemic autoimmune inflammatory disorders characterised by necrotising inflammation affecting small to medium-sized blood vessels. Despite improvements in survival, infection and cardiovascular d